Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16326 - 16350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Chenodeoxycholic acid	Approved Investigational	FABP6	2172	upregulated	Chenodeoxycholic Acid results in increased expression of FABP6 mRNA	5q33.3	A17669 A19956
Chenodeoxycholic acid	Approved Investigational	FGF19	9965	upregulated	Chenodeoxycholic Acid results in increased expression of FGF19 mRNA	11q13.3	A21599 A21600 A21591
Chenodeoxycholic acid	Approved Investigational	FTL	2512	upregulated	[Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of FTL mRNA	19q13.33	A21601
Chenodeoxycholic acid	Approved Investigational	GPBAR1	151306	upregulated	Chenodeoxycholic Acid results in increased expression of GPBAR1 mRNA	2q35	A21591
Chenodeoxycholic acid	Approved Investigational	HHEX	3087	upregulated	Chenodeoxycholic Acid results in increased expression of HHEX mRNA	10q23.33	A21588
Chenodeoxycholic acid	Approved Investigational	HMOX1	3162	upregulated	[Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA	22q12.3	A21601
Chenodeoxycholic acid	Approved Investigational	ICAM1	3383	upregulated	Chenodeoxycholic Acid results in increased expression of ICAM1 mRNA	19p13.2	A21602
Chenodeoxycholic acid	Approved Investigational	NQO1	1728	upregulated	[Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA	16q22.1	A21601
Chenodeoxycholic acid	Approved Investigational	NR0B2	8431	upregulated	[Chenodeoxycholic Acid binds to and results in increased activity of NR1H4 protein] which results in increased expression of NR0B2 mRNA	1p36.11	A20070
Chenodeoxycholic acid	Approved Investigational	NR0B2	8431	upregulated	Chenodeoxycholic Acid results in increased expression of NR0B2 mRNA	1p36.11	A21603 A21599 A21604 A21588 A21467 A21589 A21590 A21605 A21591
Chenodeoxycholic acid	Approved Investigational	NR1H4	9971	upregulated	Chenodeoxycholic Acid results in increased expression of NR1H4 mRNA	12q23.1	A21589 A21590 A21591
Chenodeoxycholic acid	Approved Investigational	PON1	5444	downregulated	Chenodeoxycholic Acid results in decreased expression of PON1 mRNA	7q21.3	A21599
Chenodeoxycholic acid	Approved Investigational	PTGS2	5743	upregulated	Chenodeoxycholic Acid results in increased expression of PTGS2 mRNA	1q31.1	A21606
Chenodeoxycholic acid	Approved Investigational	PTGS2	5743	upregulated	[SLCO1B3 protein results in increased transport of Chenodeoxycholic Acid] which results in increased expression of PTGS2 mRNA	1q31.1	A21606
Chenodeoxycholic acid	Approved Investigational	SCARB1	949	upregulated	Chenodeoxycholic Acid results in increased expression of SCARB1 mRNA	12q24.31	A21605
Chenodeoxycholic acid	Approved Investigational	SELE	6401	upregulated	Chenodeoxycholic Acid results in increased expression of SELE mRNA	1q24.2	A21602
Chenodeoxycholic acid	Approved Investigational	SLC10A1	6554	downregulated	Chenodeoxycholic Acid results in decreased expression of SLC10A1 mRNA	14q24.1	A21591
Chenodeoxycholic acid	Approved Investigational	SLC51A	200931	upregulated	Chenodeoxycholic Acid results in increased expression of SLC51A mRNA	3q29	A21587 A21467 A21589 A21590 A21607 A21591
Chenodeoxycholic acid	Approved Investigational	SLC51B	123264	upregulated	Chenodeoxycholic Acid results in increased expression of SLC51B mRNA	15q22.31	A21587 A21467 A21589 A21607 A21591
Chenodeoxycholic acid	Approved Investigational	SLCO1B3	28234	upregulated	Chenodeoxycholic Acid results in increased expression of SLCO1B3 mRNA	12p12.2	A21591
Chenodeoxycholic acid	Approved Investigational	SREBF1	6720	downregulated	Chenodeoxycholic Acid results in decreased expression of SREBF1 mRNA	17p11.2	A21599
Chenodeoxycholic acid	Approved Investigational	SULT2A1	6822	downregulated	Chenodeoxycholic Acid results in decreased expression of SULT2A1 mRNA	19q13.33	A21604
Chenodeoxycholic acid	Approved Investigational	TXN	7295	upregulated	[Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of TXN mRNA	9q31.3	A21601
Chenodeoxycholic acid	Approved Investigational	UGT1A3	54659	upregulated	Chenodeoxycholic Acid results in increased expression of UGT1A3 mRNA	2q37.1	A21608
Chenodeoxycholic acid	Approved Investigational	UGT2B4	7363	upregulated	Chenodeoxycholic Acid results in increased expression of UGT2B4 mRNA	4q13.3	A21609

Displaying entries 16326 - 16350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability